Treace Medical Concepts, Inc. SEC filings TMCI

Treace Medical Concepts, Inc. has 445 filings in SEC EDGAR's recent list, going back to Jan 21, 2015. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Treace Medical Concepts, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 6, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 6, 2026 Nov 6, 2026
4 Insider transaction Oct 28, 2026 Oct 24, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Aug 24, 2026 Aug 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 12, 2026 Aug 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2026 —
4 Insider transaction Aug 12, 2026 Aug 9, 2026
4 Insider transaction Aug 12, 2026 Aug 9, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 7, 2026 Aug 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 30, 2026 —
4/A Filing Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 1, 2026 Jun 1, 2026
4 Insider transaction May 28, 2026 May 26, 2026
8-K Current report
Shareholder vote results
May 20, 2026 May 19, 2026
4 Insider transaction May 19, 2026 May 19, 2026
4 Insider transaction May 19, 2026 May 19, 2026
4 Insider transaction May 19, 2026 May 19, 2026
4 Insider transaction May 19, 2026 May 19, 2026
4 Insider transaction May 19, 2026 May 19, 2026
4 Insider transaction May 19, 2026 May 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 14, 2026 May 12, 2026
SCHEDULE 13G Ownership over 5% (passive) May 14, 2026 —
S-8 Employee stock plan registration May 8, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 8, 2026 May 8, 2026
4 Insider transaction Apr 20, 2026 Apr 17, 2026
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Apr 9, 2026 Apr 8, 2026
ARS Annual report to shareholders Apr 6, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 6, 2026 —
DEF 14A Proxy statement Apr 6, 2026 Apr 3, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Mar 11, 2026 Mar 8, 2026
4 Insider transaction Mar 11, 2026 Mar 8, 2026
4 Insider transaction Mar 11, 2026 Mar 8, 2026
4 Insider transaction Mar 11, 2026 Mar 8, 2026
10-K Annual report Feb 27, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 27, 2026 Feb 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
4 Insider transaction Feb 11, 2026 Feb 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 9, 2026 —
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 13, 2026 Jan 10, 2026
4 Insider transaction Jan 13, 2026 Jan 10, 2026
4 Insider transaction Jan 13, 2026 Jan 10, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2026 Jan 13, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Change to shareholder rights, Regulation FD disclosure, Other events
Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 12, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations, Officer or director change
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Oct 28, 2025 Oct 24, 2025
4 Insider transaction Oct 28, 2025 Oct 25, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 15, 2025 —
4 Insider transaction Aug 12, 2025 Aug 9, 2025
4 Insider transaction Aug 12, 2025 Aug 9, 2025
4 Insider transaction Aug 12, 2025 Aug 9, 2025
4 Insider transaction Aug 12, 2025 Aug 9, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Jul 22, 2025 Jul 18, 2025
4 Insider transaction May 21, 2025 May 20, 2025
4 Insider transaction May 21, 2025 May 20, 2025
4 Insider transaction May 21, 2025 May 20, 2025
4 Insider transaction May 21, 2025 May 20, 2025
4 Insider transaction May 21, 2025 May 20, 2025
4 Insider transaction May 21, 2025 May 20, 2025
4 Insider transaction May 21, 2025 May 20, 2025
8-K Current report
Shareholder vote results
May 21, 2025 May 21, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
4 Insider transaction May 12, 2025 May 8, 2025
S-8 Employee stock plan registration May 9, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
DEF 14A Proxy statement Apr 7, 2025 Apr 7, 2025
ARS Annual report to shareholders Apr 7, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Apr 7, 2025 Apr 7, 2025
DEFA14A Additional proxy material Apr 7, 2025 —
4 Insider transaction Mar 19, 2025 Mar 17, 2025
144 Notice of proposed sale Mar 17, 2025 —
4 Insider transaction Mar 11, 2025 Mar 8, 2025
4 Insider transaction Mar 11, 2025 Mar 8, 2025
4 Insider transaction Mar 11, 2025 Mar 8, 2025
4 Insider transaction Mar 11, 2025 Mar 8, 2025
4 Insider transaction Mar 11, 2025 Mar 8, 2025
4 Insider transaction Mar 4, 2025 Mar 4, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 3, 2025 —
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Dec 5, 2024 Dec 1, 2024
3 Initial insider ownership Dec 5, 2024 Dec 1, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 13, 2024 Nov 11, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 7, 2024 —
10-Q Quarterly report Nov 5, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 5, 2024 Nov 5, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
8-K Current report
Regulation FD disclosure
Oct 15, 2024 Oct 14, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Sep 17, 2024 Sep 17, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 15, 2024 Aug 14, 2024
4 Insider transaction Aug 9, 2024 Aug 9, 2024
4 Insider transaction Aug 9, 2024 Aug 9, 2024
4 Insider transaction Aug 9, 2024 Aug 9, 2024
4 Insider transaction Aug 9, 2024 Aug 9, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jun 11, 2024 Jun 11, 2024
4 Insider transaction Jun 3, 2024 May 31, 2024
4 Insider transaction May 30, 2024 May 29, 2024
4 Insider transaction May 29, 2024 May 28, 2024
4 Insider transaction May 28, 2024 May 24, 2024
4 Insider transaction May 23, 2024 May 22, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
8-K Current report
Shareholder vote results
May 22, 2024 May 21, 2024
4 Insider transaction May 20, 2024 May 17, 2024
4 Insider transaction May 14, 2024 May 14, 2024
4 Insider transaction May 14, 2024 May 14, 2024
4 Insider transaction May 13, 2024 May 10, 2024
4 Insider transaction May 13, 2024 May 10, 2024
4 Insider transaction May 13, 2024 May 10, 2024
4 Insider transaction May 13, 2024 May 10, 2024
4 Insider transaction May 13, 2024 May 10, 2024
S-8 Employee stock plan registration May 9, 2024 —
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2024 May 7, 2024
DEFA14A Additional proxy material Apr 2, 2024 —
DEF 14A Proxy statement Apr 2, 2024 Apr 2, 2024
ARS Annual report to shareholders Apr 2, 2024 Dec 31, 2023
4 Insider transaction Mar 29, 2024 Nov 15, 2022
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 27, 2024 Feb 27, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
4 Insider transaction Jan 12, 2024 Jan 10, 2024
4 Insider transaction Jan 12, 2024 Jan 10, 2024
4 Insider transaction Jan 12, 2024 Jan 10, 2024
4 Insider transaction Jan 12, 2024 Jan 10, 2024
4 Insider transaction Jan 12, 2024 Jan 10, 2024
8-K Current report
Regulation FD disclosure
Jan 10, 2024 Jan 9, 2024
8-K Current report
Results of operations
Jan 8, 2024 Jan 8, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
4 Insider transaction Nov 3, 2023 Nov 2, 2023
4 Insider transaction Nov 3, 2023 Nov 2, 2023
4 Insider transaction Oct 5, 2023 Oct 3, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
144 Notice of proposed sale Jun 14, 2023 —
8-K Current report
Acquisition or sale of assets
Jun 13, 2023 Jun 12, 2023
4 Insider transaction Jun 8, 2023 Jun 2, 2023
144 Notice of proposed sale Jun 5, 2023 —
144 Notice of proposed sale Jun 2, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Jun 1, 2023 Jun 1, 2023
8-K Current report
Shareholder vote results
May 26, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023
4 Insider transaction May 25, 2023 May 23, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TMCI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Ponte Vedra, FL
SEC filer status
Accelerated filer
SEC CIK
1630627

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.